Ritzman Pharmacy recognizes local students
WADSWORTH, Ohio — Ritzman Pharmacy at NEOMED has introduced Ritzman Recognizes, a new awards program celebrating local high school students’ achievements in four categories – athletics, service, leadership and academics.
“We’re excited to give back where we work and live,” stated Hannah Cross, managing pharmacist at Ritzman Pharmacy’s NEOMED location. “By recognizing great kids, we hope to inspire them and others to continue excelling in the areas that improve the overall wellbeing of our communities. Ritzman Recognizes also supports who we are as a neighborhood pharmacy – a place where customers receive a level of personal service and caliber of care they won’t get anywhere else.”
Award recipients will receive a $10 Ritzman Pharmacy gift card, a certificate of excellence, their photo on display at Ritzman Pharmacy at NEOMED during the month of their recognition, and mention on Ritzman Pharmacy’s website and social media channels.
Eligible students must be in grades 9 through 12 and attend school in one of the following districts: Rootstown Local Schools, Bio-Med Science Academy, Waterloo Local Schools and Southeast Local Schools. They must also be in good academic standing with a grade point average greater than 2.5.
Community members can nominate a student by completing the nomination form online at www.ritzmanrx.com or in person at the Ritzman Pharmacy at NEOMED.
CVS Health brings prescription-free naloxone to Kansas locations
WOONSOCKET, R.I. — Kansans can now access opioid overdose reversal drug naloxone at CVS Pharmacy locations in the state. CVS Health on Tuesday announced the drug’s availability without the need for a prescription at all of its 53 Kansas locations, including those inside of Target stores, through a statewide regulatory protocol.
“Naloxone is a safe and effective antidote to opioid overdoses and by expanding access to this medication in our pharmacies in Kansas we can help save lives,” CVS Pharmacy VP pharmacy professional services Tom Davis said. “CVS Health is dedicated to helping the communities we serve address and prevent prescription drug abuse and we are expanding access to naloxone to give more people a chance to get the help they need for recovery.”
Kansas is now the 43rd state where CVS Pharmacy patients can access naloxone without a prescription. Naloxone availability is part of the chain’s efforts to combat prescription drug abuse and misuse, with other efforts including its Pharmacists Teach campaign and its collaboration with the Partnership for Drug-Free Kids, the Medication Disposal for Safer Communities Program, which donates disposal units to local police departments.
“The new Kansas law making opioid antagonist medications, such as naloxone, available without a prescription will save lives only with the support of pharmacies to make the medications available,” Kansas attorney general Derek Schmidt said. “I applaud CVS for its commitment to this effort.”
Diplomat acquires Focus Rx
FLINT, Mich. — Diplomat Pharmacy has a new addition to its ranks. The company on Monday announced the closing of its acquisition of Focus Rx Pharmacy Services, a New York-based specialty and infusion pharmacy with two locations in the state.
Focus Rx offers home infusion and specialty prescription management services, and its acquisition will strengthen Diplomat’s ability to deliver solutions for increasing infusion therapy demand, the company said.
“This partnership opens growth opportunities, especially in the key markets of New York and New Jersey,” Diplomat VP and president of Diplomat Specialty Infusion Group Phil Rielly said. “Focus Rx brings over 15 regional and national payor contracts, boosting Diplomat’s prescription and payer access.”
Diplomat said Focus Rx’s nutrition deficiency business would complement its existing Thrive Rx nutrition division of Diplomat Specialty Infusion Group, offering growth in the New York market. The company expects Focus Rx to generate roughly $47 million in revenue and $3 million in earnings before interest, taxes, depreciation and amortization for the full year 2017.
“As a specialty infusion provider in today’s rapidly evolving health care environment, we are excited to partner with Diplomat to enhance the delivery of comprehensive and personalized services to our patients,” Focus Rx CEO Lou Puleo said. “Our efforts improve patient results, as well as the clinical, operational, and financial well-being of our partners. Diplomat will further our commitment, enabling us to deliver integrated health care services to new and existing consumers and advancing our strong clinical expertise.”